We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Celanese Plans to Divest Micromax Business to Deleverage
Read MoreHide Full Article
Celanese Corporation (CE - Free Report) recently announced its plans to divest its Micromax portfolio of products to accelerate its cash generation and deleveraging strategy, its current priority.
With regular review of the assets, CE is exploring various opportunities for cash generation, including the divestiture of the Micromax portfolio. Micromax, being a leading supplier of advanced electronic inks and pastes, is expected to generate more than $300 million in revenues in 2025. Its products are known for durability, flexibility, and performance in harsh environments. It offers solutions to a diverse range of industries, including aerospace, healthcare and transportation.
Although no assurance was given regarding the form that a transaction may take or the specific terms or timing, or that a sale will in fact occur, CE expects this divestiture to sharpen its focus on high-growth assets. The closure of any such transaction will be contingent upon various conditions and approvals, including approval by the board of CE and regulatory clearances.
CE stock has lost 66.3% over the past year compared with the industry’s 1.7% decline.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.64 per share, implying a 17.14% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters, while missing the rest.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $3.92 per share, indicating a 12.64% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed it in one, with an average surprise of 32.41%. NEM’s shares have soared 16% in the past year.
The Zacks Consensus Estimate for IDR’s 2025 earnings is pegged at 78 cents per share, indicating a rise of 16.4% from year-ago levels. IDR’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest, with the average surprise being roughly 21.70%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Celanese Plans to Divest Micromax Business to Deleverage
Celanese Corporation (CE - Free Report) recently announced its plans to divest its Micromax portfolio of products to accelerate its cash generation and deleveraging strategy, its current priority.
With regular review of the assets, CE is exploring various opportunities for cash generation, including the divestiture of the Micromax portfolio. Micromax, being a leading supplier of advanced electronic inks and pastes, is expected to generate more than $300 million in revenues in 2025. Its products are known for durability, flexibility, and performance in harsh environments. It offers solutions to a diverse range of industries, including aerospace, healthcare and transportation.
Although no assurance was given regarding the form that a transaction may take or the specific terms or timing, or that a sale will in fact occur, CE expects this divestiture to sharpen its focus on high-growth assets. The closure of any such transaction will be contingent upon various conditions and approvals, including approval by the board of CE and regulatory clearances.
CE stock has lost 66.3% over the past year compared with the industry’s 1.7% decline.
Image Source: Zacks Investment Research
CE’s Zacks Rank and Key Picks
CE currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Akzo Nobel N.V. (AKZOY - Free Report) , Newmont Corporation (NEM - Free Report) and Idaho Strategic Resources, Inc. (IDR - Free Report) . While AKZOY sports a Zacks Rank #1 (Strong Buy), NEM and IDR currently carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.64 per share, implying a 17.14% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters, while missing the rest.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $3.92 per share, indicating a 12.64% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed it in one, with an average surprise of 32.41%. NEM’s shares have soared 16% in the past year.
The Zacks Consensus Estimate for IDR’s 2025 earnings is pegged at 78 cents per share, indicating a rise of 16.4% from year-ago levels. IDR’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest, with the average surprise being roughly 21.70%.